Why Young Women Have More Adverse Outcomes After a Heart Attack Than Young Men

Translate to Spanish or other 102 languages!

Younger women who have had a heart attack have more adverse outcomes and are more likely to return to the hospital in the year following their heart attack than men of a similar age. Image for illustration purposes
Younger women who have had a heart attack have more adverse outcomes and are more likely to return to the hospital in the year following their heart attack than men of a similar age. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers say younger women tend to have worse outcomes after having a heart attack than younger men.
  • They add that younger women are also more likely to return to the hospital in the year following a heart attack.
  • Experts say among other factors younger women tend to wait longer to seek treatment after experiencing heart ailments.

Younger women who have had a heart attack have more adverse outcomes and are more likely to return to the hospital in the year following their heart attack than men of a similar age. 

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/young-women-more-likely-to-return-to-the-hospital-in-year-following-heart-attack-emb?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-05-02&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -